Project aims to identify potential subgroups for escalating and de-escalating treatment in breast cancer by combined use of clinical–pathological data genomic data (Copy Number Variations and epigenetic alterations).
|Effective start/end date||1/04/19 → 31/03/20|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.